Side-by-side financials for APVO and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | APVO | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $3.11M | - |
| Net income (latest FY) | -$25.97M | - |
| Net margin | -833.9% | - |
| SEC filings | 690 | 1,002 |
Full pages: Aptevo Therapeutics Inc. and AstraZeneca PLC, or browse the full rankings.